Assembly Biosciences, Inc. (ASMB)
34.07
-0.73
(-2.10%)
USD |
NASDAQ |
Aug 28, 16:00
34.00
-0.07
(-0.21%)
After-Hours: 20:00
Assembly Biosciences Market Cap : 676.30M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 676.30M |
| August 27, 2026 | 690.79M |
| August 26, 2026 | 703.10M |
| August 25, 2026 | 701.31M |
| August 24, 2026 | 700.32M |
| August 21, 2026 | 682.45M |
| August 20, 2026 | 665.58M |
| August 19, 2026 | 671.73M |
| August 18, 2026 | 637.79M |
| August 17, 2026 | 595.71M |
| August 14, 2026 | 654.07M |
| August 13, 2026 | 594.52M |
| August 12, 2026 | 537.15M |
| August 11, 2026 | 541.32M |
| August 10, 2026 | 424.96M |
| August 07, 2026 | 424.01M |
| August 06, 2026 | 420.35M |
| August 05, 2026 | 421.70M |
| August 04, 2026 | 420.20M |
| August 03, 2026 | 403.03M |
| July 31, 2026 | 399.06M |
| July 30, 2026 | 414.16M |
| July 29, 2026 | 399.06M |
| July 28, 2026 | 406.37M |
| July 27, 2026 | 411.77M |
| Date | Value |
|---|---|
| July 24, 2026 | 406.05M |
| July 23, 2026 | 400.81M |
| July 22, 2026 | 413.84M |
| July 21, 2026 | 420.67M |
| July 20, 2026 | 398.26M |
| July 17, 2026 | 426.08M |
| July 16, 2026 | 410.66M |
| July 15, 2026 | 424.80M |
| July 14, 2026 | 425.28M |
| July 13, 2026 | 428.46M |
| July 10, 2026 | 435.45M |
| July 09, 2026 | 442.92M |
| July 08, 2026 | 456.59M |
| July 07, 2026 | 460.32M |
| July 06, 2026 | 459.21M |
| July 02, 2026 | 440.86M |
| July 01, 2026 | 424.17M |
| June 30, 2026 | 436.72M |
| June 29, 2026 | 428.46M |
| June 26, 2026 | 424.96M |
| June 25, 2026 | 385.55M |
| June 24, 2026 | 407.16M |
| June 23, 2026 | 425.92M |
| June 22, 2026 | 399.69M |
| June 18, 2026 | 388.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 180.79B |
| BridgeBio Pharma, Inc. | 14.96B |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
Market Cap Related Metrics
| PS Ratio | 7.317 |
| Price to Book Value | 2.213 |
| Price | 34.07 |
| Earnings Yield | -0.22% |